MOXISEPT I.V. is an intravenous infusion containing Moxifloxacin, a broad-spectrum antibiotic belonging to the fluoroquinolone class. It is used for the treatment of a variety of bacterial infections, especially in cases where oral antibiotics are not suitable or when rapid onset of action is needed.
MOXISEPT I.V. is used for the treatment of moderate to severe bacterial infections, including:
Moxifloxacin is effective against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, making it a versatile choice for serious infections.
Route of Administration: Intravenous infusion.
Typical Dose for Adults:
- General Infections: 400mg of Moxifloxacin administered via intravenous infusion once daily.
- Severe Infections: The same dose of 400mg is commonly used for more severe infections, with adjustments based on clinical response.
Duration of Therapy: Typically administered for 5 to 14 days depending on the severity and type of infection.
Administration: The infusion should be administered over a period of 60 minutes. Do not administer as a rapid IV push or bolus.
- For IV administration, dilute the infusion in a compatible diluent (e.g., sodium chloride or dextrose) as per guidelines.
Hypersensitivity: Avoid in patients with known hypersensitivity to Moxifloxacin, other quinolones, or any component of the infusion.
QT Interval Prolongation: Moxifloxacin may prolong the QT interval and should be used with caution in patients with a history of arrhythmia or other heart conditions.
Tendinitis and Tendon Rupture: Fluoroquinolones, including Moxifloxacin, have been associated with tendon damage, especially in elderly patients or those on corticosteroid therapy.
Renal and Hepatic Impairment: Dose adjustment may be required in patients with severe renal or hepatic dysfunction.
Seizures: Use with caution in patients with a history of seizures or central nervous system disorders.
Pregnancy and Breastfeeding: Moxifloxacin should be used during pregnancy only if the benefits outweigh the risks. It is excreted in breast milk, so caution is advised during breastfeeding.
Superinfection: Prolonged use may lead to superinfection with non-susceptible organisms, including fungi.
Broad-Spectrum Antibiotic: Effective against a wide range of pathogens, including Gram-positive, Gram-negative, and anaerobic bacteria, making it useful for various serious infections.
Once-Daily Dosing: Simplifies treatment regimens, typically requiring only one dose per day, even for severe infections.
Rapid Onset of Action: The intravenous formulation provides rapid therapeutic levels, ideal for serious infections or patients who cannot take oral antibiotics.
Effective for Complicated Infections: Especially effective for treating complicated respiratory, skin, soft tissue, and abdominal infections.
Convenient for Hospital Use: The IV formulation is ideal for hospitalized patients or those requiring immediate treatment, allowing for efficient dosing and minimal need for frequent administration.